|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/28 | |
| A61P 3/10 | |||
| C07K 14/62 |
| (11) | Number of the document | 2869830 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13734772.0 |
| Date of filing the European patent application | 2013-07-08 | |
| (97) | Date of publication of the European application | 2015-05-13 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/064392 |
| Date | 2013-07-08 |
| (87) | Number | WO 2014/009316 |
| Date | 2014-01-16 |
| (30) | Number | Date | Country code |
| 12175525 | 2012-07-09 | EP | |
| 201261671912 P | 2012-07-16 | US | |
| 13157728 | 2013-03-05 | EP | |
| 201361778556 P | 2013-03-13 | US |
| (72) |
PRIDAL, Lone, DK
NAVER, Helle, DK
MADSEN, Peter, DK
KJELDSEN, Thomas B rglum, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | NOVEL USE OF INSULIN DERIVATIVES |
| NOVEL USE OF INSULIN DERIVATIVES |